Maravai Lifesciences Holdings (MRVI) Prepaid Assets (2020 - 2026)
Maravai Lifesciences Holdings (MRVI) recorded quarterly Prepaid Assets of $11.9 million in Q1 2026, down 10.7% quarter-over-quarter from $13.4 million in Q4 2025, and down 7.91% on a YoY basis from $13.0 million in Q1 2025.
Maravai Lifesciences Holdings (MRVI) Prepaid Assets (2020 - 2026) Analysis & Trends
Maravai Lifesciences Holdings' Prepaid Assets history runs 7 years deep, the most recent figure standing at $11.9 million for Q1 2026.
- In Q1 2026, Prepaid Assets fell 7.91% year-over-year to $11.9 million; the TTM figure through Mar 2026 stood at $11.9 million (down 7.91% YoY), while the FY2025 annual figure was $13.4 million, down 26.33% from the prior year.
- Prepaid Assets was $11.9 million for Q1 2026 at Maravai Lifesciences Holdings, down from $13.4 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $25.8 million in Q4 2022 to a low of $11.9 million in Q1 2026.
- Historically, Prepaid Assets has averaged $18.6 million across 5 years, with a median of $18.1 million in 2024.
- The sharpest annual moves came in 2022 and 2024: Prepaid Assets jumped 78.31% in 2022, then plunged 34.13% in 2024.
- A 5-year view of Prepaid Assets shows it stood at $25.8 million in 2022, then dropped by 26.55% to $18.9 million in 2023, then decreased by 4.24% to $18.1 million in 2024, then declined by 26.33% to $13.4 million in 2025, then fell by 10.7% to $11.9 million in 2026.
- The last three Prepaid Assets figures came in at $11.9 million (Q1 2026), $13.4 million (Q4 2025), and $14.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Maravai Lifesciences Holdings | 747.50 Mn | 739.10 Mn | 33.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.94 Mn |
| Dec 31, 2025 | 13.37 Mn |
| Sep 30, 2025 | 14.43 Mn |
| Jun 30, 2025 | 15.31 Mn |
| Mar 31, 2025 | 12.96 Mn |
| Dec 31, 2024 | 18.15 Mn |
| Sep 30, 2024 | 21.66 Mn |
| Jun 30, 2024 | 17.06 Mn |
| Mar 31, 2024 | 16.82 Mn |
| Dec 31, 2023 | 18.95 Mn |
| Sep 30, 2023 | 22.92 Mn |
| Jun 30, 2023 | 22.52 Mn |
| Mar 31, 2023 | 25.53 Mn |
| Dec 31, 2022 | 25.80 Mn |
| Sep 30, 2022 | 23.43 Mn |
| Jun 30, 2022 | 19.66 Mn |
| Mar 31, 2022 | 15.90 Mn |
| Dec 31, 2021 | 19.70 Mn |
| Sep 30, 2021 | 17.40 Mn |
| Jun 30, 2021 | 13.43 Mn |